| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.084 | 0.06 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.06 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.06 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.33 | 0.06 |